Shashidhar Ravishankar

Mapping-free variant calling using haplotype reconstruction from k-mer frequencies

Peter A. Audano, F. Vannberg, Shashidhar Ravishankar, 2017, bioRxiv.

XomAnnotate: Analysis of Heterogeneous and Complex Exome- A Step towards Translational Medicine

D. Barh, F. Blasi, Shashidhar Ravishankar, 2015, PloS one.

Serial Analysis of the T-Cell Receptor β-Chain Repertoire in People Living With HIV Reveals Incomplete Recovery After Long-Term Antiretroviral Therapy

E. Warren, D. Coffey, Shashidhar Ravishankar, 2022, Frontiers in Immunology.

The first complete genome of the simian malaria parasite Plasmodium brasilianum

Dhruviben S. Patel, F. Vannberg, J. Barnwell, 2022, Scientific Reports.

Next-Generation Sequencing and Bioinformatics Protocol for Malaria Drug Resistance Marker Surveillance

Dhruviben S. Patel, F. Vannberg, S. Madison‐Antenucci, 2018, Antimicrobial Agents and Chemotherapy.

RNA helicase, DDX3X, is actively recruited to sites of DNA damage in live cells.

E. Warren, Shashidhar Ravishankar, M. Cargill, 2021, DNA repair.

Targeted deep amplicon sequencing of antimalarial resistance markers in Plasmodium falciparum isolates from Cameroon.

Dhruviben S. Patel, S. Schmedes, N. Lucchi, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Evolution and Genetic Diversity of the k13 Gene Associated with Artemisinin Delayed Parasite Clearance in Plasmodium falciparum

M. Cranfield, D. J. Perkins, A. Escalante, 2019, Antimicrobial Agents and Chemotherapy.

Mapping-free variant calling using haplotype reconstruction from k-mer frequencies

Fredrik Vannberg, Shashidhar Ravishankar, Peter Audano, 2017, bioRxiv.

TLR-exosomes exhibit distinct kinetics and effector function

F. Vannberg, J. B. Dixon, Shashidhar Ravishankar, 2016, Scientific Reports.

First Full Draft Genome Sequence of Plasmodium brasilianum

Dhruviben S. Patel, F. Vannberg, J. Barnwell, 2017, Genome Announcements.

Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer

E. Warren, Shashidhar Ravishankar, N. Ramnath, 2024, Scientific reports.